West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

West Pharmaceutical Services (WST) stock was upgraded to Buy at Deutsche Bank due to an attractive entry point post-selloff. Read more here.

Deutsche Bank upgraded West Pharmaceutical (WST) to Buy from Hold with a price target of $250, down from $275. The company’s Q4 results and a ...

We recently compiled a list of the Weak Earnings, Outlook Drag Shares of These 10 Firms on Thursday. In this article, we are ...

Good morning, ladies and gentlemen, and welcome to the West Fraser Q4 2024 Results Conference Call. [Operator Instructions] This call is being recorded on Thursday, February 13, 2025. During this ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The NHL is finally out of the shadow of the COVID pandemic and there are expectations that a stagnant salary cap will be a thing of the past. After a few years of a slowly increasing cap ...

Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co. This press release contains excerpts of our most recently published company report on OKYO Pharma Limited ("The ...

Shares of West Pharmaceutical Services Inc. WST shed 1.08% to $339.57 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index SPX falling 0. ...

Chief Financial Officer of NewAmsterdam Pharma, will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference on Wednesday, February 5, 2025 at 10:00 a.m. ET. A live webcast of ...

The Outsourcing in Clinical Trials (OCT) West Coast conference will take place in San Francisco ... Diversity in clinical trials on a global scale On 12 February, Archana Sah, founder of AS Pharma ...